IMPACCT: Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials
IMPACCT:肌肉骨骼儿科急性护理临床试验的基础设施
基本信息
- 批准号:10477229
- 负责人:
- 金额:$ 144万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAffectAmericanAnatomyAnesthesia proceduresAnestheticsAreaAwardChildChildhoodChildhood InjuryClient satisfactionClinicalClinical ResearchClinical TrialsClinical effectivenessComplicationConscious SedationConsensusData Coordinating CenterDevelopmentDistalEquipoiseEventFaceFractureFutureGeneral AnesthesiaGeneral anesthetic drugsGrantImmobilizationInfrastructureInjuryInterventionLeadLeadershipLocationMedialMedicineMethodsModelingMorbidity - disease rateMulti-Institutional Clinical TrialMusculoskeletalNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNorth AmericaObservational StudyOperative Surgical ProceduresOrthopedic SurgeryOrthopedicsOutcome MeasurePainParticipantPatient Outcomes AssessmentsPatient RecruitmentsPatientsPhasePositioning AttributeProceduresProtocols documentationRadius FracturesRandomizedRandomized Clinical TrialsRandomized Controlled TrialsReportingResearchResearch PersonnelRiskSavingsSedation procedureSiteSocietiesSurgeonSurveysTimeLineUnited KingdomUnnecessary ProceduresUpper ExtremityUpper Extremity FractureVariantVotingacute carebonebone healingclinical decision-makingclinical practicecostdisabilityexperiencefunctional disabilityfunctional outcomeshealinginjuredinnovationlimb injurymemberoperationpediatric traumaprimary outcomeprocedure costprospectiverecruitsecondary outcomesedativesymposiumtrauma caretreatment strategywillingness
项目摘要
ABSTRACT
The management of two common upper extremity injuries, pediatric medial epicondyle fractures (MEF)
and displaced distal radius fractures (DRF), is controversial with high practice variation. The debate largely
focusses on whether to reduce these injuries to restore their usual position or to allow the fractures to heal in
their injured position with simple immobilization. Observational studies support both reduction and simple
immobilization for MEF and DRF. In both injuries, there have been few prospective and no randomized studies
evaluating their treatment. Given the widespread variation in practice, children are either undergoing
unnecessary procedures and anesthetic events when surgeons opt for reduction under anesthesia/ conscious
sedation OR are being undertreated by simple immobilization. Both scenarios are unacceptable in that children
face either anesthetic risks and extra costs or poor alignment with potential long term functional disability
To address such clinical dilemmas, the Infrastructure for Musculoskeletal Pediatric Acute Care Clinical
Trials (IMPACCT) consortium was organized to develop the infrastructure and experience necessary for
multicenter randomized clinical trials. IMPACCT’s leadership has expertise in leading multicenter clinical trials
and its members represent 32 diverse centers from the Pediatric Orthopaedic Society of North America
(POSNA). During the IMPACCT Consensus Conference, participants agreed that that MEF and DRF have the
equipoise necessary and are the most pressing clinical controversies. A similar priority-setting study from the
United Kingdom identified these questions as important controversies in children’s orthopaedic surgery.
POSNA-wide surveys confirmed MEF and DRF treatment variation and surgeons’ willingness to randomize.
A multicenter randomized superiority trial of children with MEF and DRF is required to evaluate the
clinical effectiveness of reduction under anesthesia/sedation vs. simple immobilization. The central hypothesis
of this proposal is that children treated with reduction under general anesthesia (MEF) or conscious sedation
(DRF) will have higher patient reported outcome scores compared to those treated with simple immobilization
alone. Trials on both fractures will be conducted simultaneously to take advantage of the economy of scale and
are similar in terms of anatomic location, outcome measures, and whether an intervention is necessary. Thirty-
one sites have agreed to recruit, randomize and treat a total of 688 patients according to the pragmatic
protocols. Investigators have partnered with the Trial Innovation Network to increase the efficiency of trial
development and execution. NIAMS has awarded this initiative an R34 Clinical Trials Planning Grant. This
proposal will support the active study phase when patients are recruited, treated, and followed and when
results are analyzed and disseminated.
The completion of these trials will provide a framework, infrastructure and experience for future
prospective multicenter clinical trials in pediatric orthopaedics as its results guide clinical decision-making.
抽象的
两种常见上肢损伤的治疗:小儿上髁骨折(MEF)
和移位的桡骨远端骨折(DRF),由于实践变化很大而存在争议。
重点是是否减少这些伤害以恢复其通常的位置或让骨折愈合
观察性研究支持复位和简单固定。
对于 MEF 和 DRF 的固定,很少有前瞻性研究,也没有随机研究。
鉴于实践中存在广泛差异,儿童要么正在接受治疗。
当外科医生选择在麻醉/清醒状态下复位时,不必要的手术和麻醉事件
镇静或简单固定治疗不足,这两种情况对于儿童来说都是不可接受的。
要么面临麻醉风险和额外费用,要么面临潜在的长期功能障碍
为了解决此类临床困境,肌肉骨骼儿科急性护理临床基础设施
组织试验(IMPACCT)联盟是为了开发必要的基础设施和经验
IMPACCT 的领导层在领先的多中心临床试验方面拥有专业知识。
及其成员代表北美小儿骨科协会的 32 个不同中心
(POSNA) 在 IMPACCT 共识会议上,与会者一致认为 MEF 和 DRF 拥有
平衡是必要的,也是最紧迫的临床争议。
英国将这些问题视为儿童骨科手术中的重要争议。
POSNA 范围内的调查证实了 MEF 和 DRF 治疗的差异以及外科医生随机化的意愿。
需要对 MEF 和 DRF 儿童进行多中心随机优势试验来评估
麻醉/镇静下复位与简单固定的临床效果中心假设。
该提案的主要内容是在全身麻醉(MEF)或清醒镇静下对儿童进行复位治疗
与简单固定治疗的患者相比,(DRF)患者报告的结果分数更高
两种骨折的试验将同时进行,以利用规模经济和优势。
在解剖位置、结果测量以及是否需要干预方面相似。
一个站点已同意根据务实原则招募、随机分组并治疗总共 688 名患者
研究人员与试验创新网络合作以提高试验效率。
NIAMS 已授予该计划 R34 临床试验规划补助金。
该提案将支持积极的研究阶段,即招募、治疗和随访患者,以及
结果得到分析和传播。
这些试验的完成将为未来提供框架、基础设施和经验
儿科骨科前瞻性多中心临床试验,其结果指导临床决策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph A Janicki其他文献
Joseph A Janicki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph A Janicki', 18)}}的其他基金
IMPACCT: Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials
IMPACCT:肌肉骨骼儿科急性护理临床试验的基础设施
- 批准号:
10206779 - 财政年份:2021
- 资助金额:
$ 144万 - 项目类别:
IMPACCT: Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials
IMPACCT:肌肉骨骼儿科急性护理临床试验的基础设施
- 批准号:
10684924 - 财政年份:2021
- 资助金额:
$ 144万 - 项目类别:
IMPACCT: Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials
IMPACCT:肌肉骨骼儿科急性护理临床试验的基础设施
- 批准号:
10684924 - 财政年份:2021
- 资助金额:
$ 144万 - 项目类别:
IMPACCT – Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials
IMPACCT — 肌肉骨骼儿科急性护理临床试验基础设施
- 批准号:
9977922 - 财政年份:2019
- 资助金额:
$ 144万 - 项目类别:
相似国自然基金
社会网络关系对公司现金持有决策影响——基于共御风险的作用机制研究
- 批准号:72302067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高尿酸调控TXNIP驱动糖代谢重编程影响巨噬细胞功能
- 批准号:82370895
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
倒装芯片超声键合微界面结构演变机理与影响规律
- 批准号:52305599
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
寒地城市学区建成环境对学龄儿童心理健康的影响机制与规划干预路径研究
- 批准号:52378051
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
原位研究聚变燃料纯化用Pd-Ag合金中Ag对辐照缺陷演化行为的影响及其相互作用机制
- 批准号:12305308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 144万 - 项目类别:
Identifying and testing a tailored strategy to achieve equity in blood pressure control in PACT
确定并测试量身定制的策略,以在 PACT 中实现血压控制的公平性
- 批准号:
10538513 - 财政年份:2023
- 资助金额:
$ 144万 - 项目类别:
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
- 批准号:
10594743 - 财政年份:2023
- 资助金额:
$ 144万 - 项目类别:
1/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership
1/2 药物开发和能力建设:UCR/CoH-CCC 合作伙伴关系
- 批准号:
10762157 - 财政年份:2023
- 资助金额:
$ 144万 - 项目类别:
Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
- 批准号:
10735151 - 财政年份:2023
- 资助金额:
$ 144万 - 项目类别: